Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
Episodes 31-45 of 469
Advancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Clinician's RoundtableAdvancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Rising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
Clinician's RoundtableRising Stimulant Use Among Patients with HIV: What 5 Years of Clinic Data Reveal
LUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
NeuroFrontiersLUMINESCE: Assessing Satralizumab in Generalized Myasthenia Gravis
Advancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
NeuroFrontiersAdvancements in gMG Management: Zilucoplan as an Alternative to C5 Inhibitors
Examining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
NeuroFrontiersExamining Inebilizumab in Generalized Myasthenia Gravis: Insights from MINT
Overcoming Barriers in Dry Eye Disease Care: Current and Emerging Options
Eye on Ocular HealthOvercoming Barriers in Dry Eye Disease Care: Current and Emerging Options
- advertisement
Evaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Eye on Ocular HealthEvaluating Eyelid Wipes for Dry Eye Disease: Clinical Trial Insights
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Navigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Clinician's RoundtableNavigating Pediatric Obesity: Tools and Strategies for Success in Primary Care
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living RheumDelaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Rewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
FCDC Action CenterRewriting the Rules of Psoriasis Severity: A Global Shift Toward Impact-Driven Care
How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
FCDC Action CenterHow Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
- advertisement
Improving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
FCDC Action CenterImproving Psoriatic Disease Care Through Dermatology–Rheumatology Clinics
Combination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
FCDC Action CenterCombination Therapy for Plaque Psoriasis: A Reappraisal of Cyclosporine and Acitretin
Improved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Clinician's RoundtableImproved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
